The effect of surgical timing in nonmetastatic melanoma

Abstract

AbstractBackground and ObjectivesThere is no consensus guidelines on the best timing to perform Sentinel lymph node biopsy (SLNB) in high‐risk melanoma patients. We aimed to understand the impact of surgical timing on nodal upstaging in patients with cutaneous melanoma.MethodsWe queried the National Cancer Database from 2004 to 2018 for patients with T2–T4, N0, M0 melanomas, who underwent melanoma excision and nodal surgery. We included patients who underwent surgery within 2–19 weeks postdiagnosis. We aimed to determine the association of surgical delay (weeks) with nodal positivity.ResultsA total of 53 355 patients were included, of whom 20.9% had positive lymph nodes. Patients underwent surgery at a median of 5 (4–7) weeks after diagnosis. The rate of positive nodes increased with increased weeks to surgery (line of best‐fit slope = 0.38). Multivariable regression analysis identified an association between time to surgery and nodal positivity (2.4% increased risk per week, p < 0.05). Our analysis showed significantly increased likelihood of nodal positivity beginning 9 weeks after diagnosis (odds ratio [OR] = 1.3, p < 0.05). Furthermore, patients with T2–3 tumors had a significant increase in nodal positivity with increased time to surgery (OR = 1.03 per week, p < 0.001). However, no significant trend in nodal positivity was identified for patients with T4 melanomas (OR = 1.01 per week, p = 0.596).ConclusionSurgery within 9 weeks of melanoma diagnosis was not associated with increased likelihood of nodal positivity. These data can guide clinical conversations regarding the importance of surgical timing for melanoma.